Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Aprotinin Inhibits SARS-CoV-2 Replication.
Bojkova D, Bechtel M, McLaughlin KM, McGreig JE, Klann K, Bellinghausen C, Rohde G, Jonigk D, Braubach P, Ciesek S, Münch C, Wass MN, Michaelis M, Cinatl J Jr. Bojkova D, et al. Among authors: mclaughlin km. Cells. 2020 Oct 30;9(11):2377. doi: 10.3390/cells9112377. Cells. 2020. PMID: 33143316 Free PMC article.
COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?
McLaughlin KM, Bechtel M, Bojkova D, Münch C, Ciesek S, Wass MN, Michaelis M, Cinatl J Jr. McLaughlin KM, et al. Diagnostics (Basel). 2020 Jul 30;10(8):539. doi: 10.3390/diagnostics10080539. Diagnostics (Basel). 2020. PMID: 32751741 Free PMC article.
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis.
McLaughlin KM, Bojkova D, Kandler JD, Bechtel M, Reus P, Le T, Rothweiler F, Wagner JUG, Weigert A, Ciesek S, Wass MN, Michaelis M, Cinatl J Jr. McLaughlin KM, et al. Curr Issues Mol Biol. 2021 Sep 22;43(3):1212-1225. doi: 10.3390/cimb43030086. Curr Issues Mol Biol. 2021. PMID: 34698067 Free article.
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.
Rothenburger T, Thomas D, Schreiber Y, Wratil PR, Pflantz T, Knecht K, Digianantonio K, Temple J, Schneider C, Baldauf HM, McLaughlin KM, Rothweiler F, Bilen B, Farmand S, Bojkova D, Costa R, Ferreirós N, Geisslinger G, Oellerich T, Xiong Y, Keppler OT, Wass MN, Michaelis M, Cinatl J Jr. Rothenburger T, et al. Among authors: mclaughlin km. J Exp Clin Cancer Res. 2021 Oct 12;40(1):317. doi: 10.1186/s13046-021-02093-4. J Exp Clin Cancer Res. 2021. PMID: 34641952 Free PMC article.
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line.
Saafan H, Alahdab A, Michelet R, Gohlke L, Ziemann J, Holdenrieder S, McLaughlin KM, Wass MN, Cinatl J Jr, Michaelis M, Kloft C, Ritter CA. Saafan H, et al. Among authors: mclaughlin km. Cells. 2021 Mar 24;10(4):716. doi: 10.3390/cells10040716. Cells. 2021. PMID: 33804833 Free PMC article.